Please login to read the full article.
Scrip Regulatory Affairs
The new EU pharmacovigilance rules: a disproportionate burden on industry?
16 March 2011
Liesbeth Weynants, Carla Schoonderbeek
Please login to read the full article.
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- Pharma wins reduction in data requirements for EU EVMPD product database
- European Commission seeks feedback on measures for implementing pharmacovigilance legislation
- European industry bodies voice concern over CoE's anti-counterfeiting system
- UK consults on transposing EU pharmacovigilance rules into national law
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
